Hi @bruce_haigh - I can't help with the politics, but I might be able to help with the maths.
As a person in their 70s in Australia, if you had gotten COVID last year, on average you'd have a 38% chance of being hospitalized, a 7% chance of going to ICU, and a 10% chance of dying.
Obviously not everyone got infected, but during 2020, 6 in every 100,000 (1 in 16,000) people in their 70s needed ICU for COVID, and 8 in every 100,000 (1 in 12500) people died from COVID. This was obviously higher in Victoria than elsewhere, and who knows what 2021 will bring.
You could reduce this risk in the future by getting vaccinated. If you get the AZ vaccine, there is a small risk (about 1 in 200,000 people, or 0.00005% chance) that you might get a clotting disorder.
Or you could wait for Pfizer, which doesn't seem to be associated with this rare clotting disorder. I obviously don't know your personal circumstances and you may want to discuss this with your GP. Hope that helps with your decision.
.@behrooz_hm pointed out I'd got the percentage wrong - 1 in 200,000 is 0.0005% (you get the idea - it's a rare condition)

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Allen Cheng

Allen Cheng Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @peripatetical

8 Apr
OK, has been a long week but will try to explain the ATAGI statement published tonight
health.gov.au/news/atagi-sta…
Like with all medical treatments, when we have a choice we need to consider the risks and the benefits. In this case we're thinking about the risk of a side effect due to vaccination and the benefit of a reduced risk of COVID.
A rare but serious clotting disorder (thrombosis with thrombocytopenia) has been reported after the AZ vaccine. One case has been reported in Australia to date from about 420,000 AZ vaccine doses which ATAGI noted reported on Good Friday health.gov.au/news/atagi-sta…
Read 25 tweets
12 Jan
Why would we use a vaccine that mightn't prevent transmission? Should we use one particular vaccine, or roll out the vaccines we have as broadly and quickly as possible?
I'd argue that we should use all available vaccines that prevent COVID, even if they don't reduce transmission as much as we'd like.
Vaccines can protect people both directly and indirectly. If you get an effective vaccine, you directly benefit. You have a reduced risk of getting the disease.
Read 23 tweets
4 Jan
I'm seeing commentary asking why Australia isn't just rolling out the vaccine prior to regulatory approval, or why the TGA just doesn't register the vaccine based on approvals in other countries.
A thread on what's involved in vaccine regulation. (I'm the chair of the Advisory Committee for Vaccines, which is appointed by Minister Hunt. It's the TGA's responsibility to assess drugs and vaccines but this committee provides advice)
It's obvious that vaccines need to be effective, safe and made to a high quality. Most vaccines are given to millions of people who are otherwise well to prevent disease - this is very different to treatments that are given to people who are unwell.
Read 25 tweets
20 Dec 20
A few comments on endpoints for COVID vaccine trials. For regulators, the main question when considering effectiveness is whether the vaccine reduces the risk of symptomatic COVID.
But there are two other relevant questions - whether a vaccine prevents severe disease, and whether it prevents transmission.
For the question of symptomatic COVID, the endpoint of interest is symptomatic confirmed COVID. (there are actually two definitions of this - the European ECDC and US CDC, with slightly different symptom lists - both are collected).
Read 17 tweets
15 Jul 20
A thread about the SARS-CoV-2 vaccines in development. There are a lot of candidate vaccines in development, but we still have a long way to go.
Vaccines work by training the immune system on a virus or a component that doesn't cause disease, so that it can respond more efficiently when it sees the real thing.
For SARS2, there are many different approaches being tried. These can be classed into 4 main groups - inactivated/live attenuated, protein subunits, viral vectors and nucleic acid vaccines.
Read 23 tweets
16 Jun 20
SARS-CoV-2 infection in patients that don't have symptoms. It's complicated. A thread.
Data suggest that viral load does start to increase and is maximal slightly before the onset of symptoms, although there is clearly a lot of variation between patients.
nature.com/articles/s4159…
Although it can be hard to pinpoint the exact time of transmission, it also appears that transmission can occur from people with infection before the onset of symptoms.
Read 22 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!